849 related articles for article (PubMed ID: 17414097)
61. Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.
van Gaal JC; Flucke UE; Roeffen MH; de Bont ES; Sleijfer S; Mavinkurve-Groothuis AM; Suurmeijer AJ; van der Graaf WT; Versleijen-Jonkers YM
J Clin Oncol; 2012 Jan; 30(3):308-15. PubMed ID: 22184391
[TBL] [Abstract][Full Text] [Related]
62. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
Tsuzuki T; Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1609-14. PubMed ID: 15577680
[TBL] [Abstract][Full Text] [Related]
63. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract][Full Text] [Related]
64. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin CA; Hawkins AL; Dvorak C; Henkle C; Ellingham T; Perlman EJ
Cancer Res; 1999 Jun; 59(12):2776-80. PubMed ID: 10383129
[TBL] [Abstract][Full Text] [Related]
65. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.
Lawrence B; Perez-Atayde A; Hibbard MK; Rubin BP; Dal Cin P; Pinkus JL; Pinkus GS; Xiao S; Yi ES; Fletcher CD; Fletcher JA
Am J Pathol; 2000 Aug; 157(2):377-84. PubMed ID: 10934142
[TBL] [Abstract][Full Text] [Related]
66. Myofibromas with atypical features: expanding the morphologic spectrum of a benign entity.
Linos K; Carter JM; Gardner JM; Folpe AL; Weiss SW; Edgar MA
Am J Surg Pathol; 2014 Dec; 38(12):1649-54. PubMed ID: 24921644
[TBL] [Abstract][Full Text] [Related]
67. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
[TBL] [Abstract][Full Text] [Related]
68. Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center.
Wang Z; Zhao X; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Surg Int; 2016 Mar; 32(3):239-43. PubMed ID: 26590817
[TBL] [Abstract][Full Text] [Related]
69. Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.
Devins KM; Samore W; Nielsen GP; Deshpande V; Oliva E
Mod Pathol; 2023 Jun; 36(6):100143. PubMed ID: 36806735
[TBL] [Abstract][Full Text] [Related]
70. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.
Bennett JA; Nardi V; Rouzbahman M; Morales-Oyarvide V; Nielsen GP; Oliva E
Mod Pathol; 2017 Oct; 30(10):1489-1503. PubMed ID: 28664932
[TBL] [Abstract][Full Text] [Related]
71. Pediatric inflammatory myofibroblastic tumor: anaplastic lymphoma kinase (ALK) expression and prognosis.
Chun YS; Wang L; Nascimento AG; Moir CR; Rodeberg DA
Pediatr Blood Cancer; 2005 Nov; 45(6):796-801. PubMed ID: 15602716
[TBL] [Abstract][Full Text] [Related]
72. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
[TBL] [Abstract][Full Text] [Related]
73. Inflammatory Myofibroblastic Tumor of the Uterus: An Immunohistochemical Study of 23 Cases.
Bennett JA; Croce S; Pesci A; Niu N; Van de Vijver K; Burks EJ; Burandt E; Zannoni GF; Rabban JT; Oliva E
Am J Surg Pathol; 2020 Nov; 44(11):1441-1449. PubMed ID: 32568825
[TBL] [Abstract][Full Text] [Related]
74. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
75. Anaplastic lymphoma kinase expression in inflammatory pseudotumors.
Chan JK; Cheuk W; Shimizu M
Am J Surg Pathol; 2001 Jun; 25(6):761-8. PubMed ID: 11395553
[TBL] [Abstract][Full Text] [Related]
76. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.
Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
[TBL] [Abstract][Full Text] [Related]
77. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
78. Urachal inflammatory myofibroblastic tumor with ALK gene rearrangement: a study of urachal remnants.
Nascimento AF; Dal Cin P; Cilento BG; Perez-Atayde AR; Kozakewich HP; Nosé V
Urology; 2004 Jul; 64(1):140-4. PubMed ID: 15245952
[TBL] [Abstract][Full Text] [Related]
79. Abdominal inflammatory myofibroblastic tumor a clinicopathologic study with reappraisal of biologic behavior.
Fragoso AC; Eloy C; Estevão-Costa J; Campos M; Farinha N; Lopes JM
J Pediatr Surg; 2011 Nov; 46(11):2076-82. PubMed ID: 22075336
[TBL] [Abstract][Full Text] [Related]
80. [Clinicopathological features of inflammatory myofibroblastic tumors of the lung].
Yang H; Xie R; Xiao J; Zhang S
Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):116-9. PubMed ID: 21114933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
